Founder, CEO, GSBR Research

Garvit Bhandari

Founder, CEO

Leading Provider of Equity and Investment Research

GSBR Research

We are an independent equity research provider focused on covering global markets. The aim of the research is to provide an unbiased view of the fundamentals of the company.

Event-Driven

<ul>
<li>Vivani Medical has set Oct 8, 2025 as teh record date for its earlier announced spin-off of its neuromodulation subsidiary, Cortigent Inc.</li>
<li>Vivani will retain its focus on its GLP-1 implant pipeline for metabolic disease. Investors get clean exposure to two very different growth narratives: neuromodulation (BCI) and drug implants.</li>
<li>If executed properly, this spin-off could unlock meaningful valuation uplift particularly for Cortigent in a promising but under-served medtech space.</li>
</ul>


Vivani Medical has set Oct 8, 2025 as teh record date for its earlier announced spin-off of its neuromodulation subsidiary, Cortigent Inc.
Vivani will retain its focus on its GLP-1 implant pipeline for metabolic disease. Investors get clean exposure to two very different growth narratives: neuromodulation (BCI) and drug implants.
If executed properly, this spin-off could unlock meaningful valuation uplift particularly for Cortigent in a promising but under-served medtech space.


Vivani Medical Prepares Spin-Off of Cortigent: Neuromodulation Gets Its Own Spotlight

United States

Vivani Medical, Inc. provides neuromodulation devices. The Company develops, manufactures, and markets implants that treat chronic diseases with high unmet medical need. Vivani Medical serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Vivani Medical (VANI US)

Vivani Medical Prepares Spin-Off of Cortigent: Neuromodulation Gets Its Own Spotlight

Vivani Medical sets record date for spin-off of Cortigent Inc., offering investors exposure to neuromodulation and drug implants with potential...

GSBR Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Vivani Medical Prepares Spin-Off of Cortigent: Neuromodulation Gets Its Own Spotlight

​Vivani Medical sets record date for spin-off of Cortigent Inc., offering investors exposure to neuromodulation and drug implants with potential...

GSBR Research

Vivani Medical sets record date for spin-off of Cortigent Inc., offering investors exposure to neuromodulation and drug implants with potential...